Literature DB >> 11827688

Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis.

Helen Kiriazis1, Yoji Sato, Vivek J Kadambi, Albrecht G Schmidt, Michael J Gerst, Brian D Hoit, Evangelia G Kranias.   

Abstract

OBJECTIVE: To determine whether the hyperdynamic phospholamban-knockout hearts are capable of withstanding a chronic aortic stenosis.
METHODS: The transverse section of the aorta was banded in phospholamban-knockout and their isogenic wild-type mice, which were followed with echocardiography in parallel, along with sham-operated mice, before and at 2.5, 5 and 10 weeks after surgery.
RESULTS: Cardiac decompensation was evidenced by the presence of lung congestion in some banded knockouts and wild-types, giving rise to a subset of non-failing and failing hearts within each group. The incidence of heart failure was not genotype-dependent but rather associated with higher heart rates before surgery. The development of left ventricular hypertrophy was similar between knockouts and wild-types and longitudinal assessment of end-diastolic dimension indicated progressive increases after banding, with a greater dilation in failing mice. Fractional shortening was reduced in failing knockouts and wild-types to a similar degree, with an earlier onset in the knockouts. In addition, fractional shortening was decreased in non-failing knockouts but not wild-types. Ejection times shortened after aortic banding particularly for failing hearts. Assessment of the SR Ca(2+)-ATPase protein levels indicated similar downregulation for failing knockouts and wild-types, while the phospholamban levels were not significantly altered in wild-types.
CONCLUSION: The hyperdynamic phospholamban-knockout hearts are able to compensate against a sustained aortic stenosis similar to wild-types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11827688     DOI: 10.1016/s0008-6363(01)00487-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

Review 1.  Model-specific selection of molecular targets for heart failure gene therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

2.  The ins and outs of calcium in heart failure.

Authors:  Brian O'Rourke
Journal:  Circ Res       Date:  2008-06-06       Impact factor: 17.367

Review 3.  Gene therapy in heart failure.

Authors:  Leif Erik Vinge; Philip W Raake; Walter J Koch
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

Review 4.  Gene therapy targets in heart failure: the path to translation.

Authors:  P W J Raake; H Tscheschner; J Reinkober; J Ritterhoff; H A Katus; W J Koch; P Most
Journal:  Clin Pharmacol Ther       Date:  2011-08-24       Impact factor: 6.875

5.  Variable phenotype in murine transverse aortic constriction.

Authors:  Selma F Mohammed; Jimmy R Storlie; Elise A Oehler; Lorna A Bowen; Josef Korinek; Carolyn S P Lam; Robert D Simari; John C Burnett; Margaret M Redfield
Journal:  Cardiovasc Pathol       Date:  2011-07-18       Impact factor: 2.185

6.  Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats.

Authors:  Yoshitaka Iwanaga; Masahiko Hoshijima; Yusu Gu; Mitsuo Iwatate; Thomas Dieterle; Yasuhiro Ikeda; Moto-o Date; Jacqueline Chrast; Masunori Matsuzaki; Kirk L Peterson; Kenneth R Chien; John Ross
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 7.  Dichotomy of Ca2+ in the heart: contraction versus intracellular signaling.

Authors:  Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

8.  Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses.

Authors:  Satoshi Okumura; Takayuki Fujita; Wenqian Cai; Meihua Jin; Iyuki Namekata; Yasumasa Mototani; Huiling Jin; Yoshiki Ohnuki; Yayoi Tsuneoka; Reiko Kurotani; Kenji Suita; Yuko Kawakami; Shogo Hamaguchi; Takaya Abe; Hiroshi Kiyonari; Takashi Tsunematsu; Yunzhe Bai; Sayaka Suzuki; Yuko Hidaka; Masanari Umemura; Yasuhiro Ichikawa; Utako Yokoyama; Motohiko Sato; Fumio Ishikawa; Hiroko Izumi-Nakaseko; Satomi Adachi-Akahane; Hikaru Tanaka; Yoshihiro Ishikawa
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

Review 9.  Beta-adrenergic stimulation and myocardial function in the failing heart.

Authors:  Ali El-Armouche; Thomas Eschenhagen
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

10.  Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart.

Authors:  Hiroyuki Nakayama; Benjamin J Wilkin; Ilona Bodi; Jeffery D Molkentin
Journal:  FASEB J       Date:  2006-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.